Choi S U, Lee J H, Oh C-K, Shin G T, Kim H, Kim S J, Kim S I
Department of Surgery, Ajou University, School of Medicine, Suwon, Gyeonggi-do, Korea.
Transplant Proc. 2013 May;45(4):1392-5. doi: 10.1016/j.transproceed.2012.10.059.
The use of new selective immunosuppressants as well as the emergence of new antimicrobial resistances raise the use of prophylactic antibiotics as a matter of controversy. The purpose of this study was to retrospectively analyze the clinical significance of prophylactic antibiotics in kidney transplantation.
This retrospective study included 174 renal allograft recipients who were divided into two groups: group A including patients who received perioperative prophylactic antibiotics and group B, who did not receive them. We analyzed who the incidence of infectious complications as well as the causative micro-organisms and their antimicrobial resistance within 1 month after kidney transplantation.
Overall bacterial infections were observed during the first postoperative month in 13 cases (7.4%): 6 (3.4%) surgical site 4 (2.3%) urinary tract, 2 (1.1%) bacteremic, and 1 (0.6%) central catheter infections. There was no respiratory infection. The incidence of bacterial infection was not significantly different between the two groups. The major micro-organisms isolated after kidney transplantation, were Staphylococcus aureus and Escherichia coli; both of which had already shown multidrug resistance at the initial time of infection.
Not only did use of prophylactic antibiotics have little impact to prevent bacterial infections after kidney transplantation, but also it may induce antimicrobial resistance against the antibiotics used for prophylaxis. Moreover, the increased antibiotic resistance prior to kidney transplantation hampers the effectiveness of prophylactic antimicrobial agents. Guidelines for perioperative antibiotic prophylaxis should be therefore revised.
新型选择性免疫抑制剂的使用以及新出现的抗菌药物耐药性使得预防性使用抗生素成为一个有争议的问题。本研究的目的是回顾性分析预防性抗生素在肾移植中的临床意义。
这项回顾性研究纳入了174例肾移植受者,他们被分为两组:A组包括接受围手术期预防性抗生素治疗的患者,B组为未接受预防性抗生素治疗的患者。我们分析了肾移植后1个月内感染并发症的发生率、致病微生物及其抗菌药物耐药性。
术后第一个月共观察到13例(7.4%)总体细菌感染:6例(3.4%)手术部位感染,4例(2.3%)泌尿系统感染,2例(1.1%)菌血症,1例(0.6%)中心导管感染。无呼吸道感染。两组之间细菌感染的发生率无显著差异。肾移植后分离出的主要微生物是金黄色葡萄球菌和大肠杆菌;两者在感染初期就已显示出多重耐药性。
预防性使用抗生素不仅对预防肾移植后细菌感染影响不大,而且可能诱导对用于预防的抗生素产生耐药性。此外,肾移植前抗生素耐药性的增加会妨碍预防性抗菌药物的有效性。因此,应修订围手术期抗生素预防指南。